Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 81A12 (CYP81A12) is a key enzyme identified in the weed species Echinochloa phyllopogon (late watergrass) that plays a critical role in conferring multiple herbicide resistance (Iwakami et al., 2014). It belongs to the CYP81A subfamily of cytochrome P450 monooxygenases, which are heme-thiolate enzymes involved in the oxidative metabolism of both endogenous compounds and xenobiotics (Iwakami et al., 2014; Pest Manag Sci, 2022). CYP81A12 specifically catalyzes the detoxification of acetolactate synthase (ALS) inhibitors, such as bensulfuron-methyl and penoxsulam, primarily through O-demethylation reactions (Iwakami et al., 2014; Plant Physiology, 2014). It has also been implicated in the metabolism of acetyl-CoA carboxylase (ACCase) inhibitors and other herbicide groups, contributing to a broad-spectrum resistance phenotype known as non-target-site resistance (Frontiers in Plant Science, 2020). While not a target for human therapeutic intervention, CYP81A12 is a critical target in agricultural biotechnology for the development of herbicide synergists and the engineering of herbicide-tolerant crops (Pest Manag Sci, 2022). Understanding the regulatory mechanisms and substrate specificity of CYP81A12 is essential for addressing the global challenge of herbicide-resistant weeds in rice production and other agricultural systems (Iwakami et al., 2014; ResearchGate, 2014).
Metabolic inactivation of herbicides through oxidative reactions such as O-demethylation and hydroxylation, leading to reduced phytotoxicity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 81A12 (CYP81A12).